. Author manuscript; available in PMC: 2023 Sep 12.

Published in final edited form as: Vaccine. 2022 Feb 15;40(Suppl 1):A67–A76. doi: 10.1016/j.vaccine.2022.01.024

Table 6.

Weighted cost by resource input (2020 US$) (January 2018–June 2019).^±

Resource Input	FINANCIAL		ECONOMIC
Resource Input	Total Weighted Costs (95% C.I.)	% of Total	Total Weighted Costs (95% C.I.)	% of Total
Per diem ^*	$619,892 ($438,851–$800,933)	75	$619,892 ($438,851–$800,933)	30
Transportation	$145,930 ($27,728–$264,132)	17	$279,762 ($153,217–$406,308)	14
Venue	$38,831 ($11,545–$66,116)	4	$244,230 ($136,529–$351,931)	11
Non-vaccination supplies and materials	$24,070 ($3,224–$44,917)	3	$72,946 ($34,527–$111,366)	3
Personnel time	$0^** ($0–$0)	0^**	$841,456 ($549,901–$1,133,011)	41
Equipment	$9 ($0–$26)	<1	$2657 ($0–$7,828)	<1
TOTAL	$828,731 ($573,892–$1,083,571)	100	$2,060,943 ($1,554,092–$2,567,794)	100

Abbreviations: C.I. = confidence interval.

^±

Not including additional cost of reaching out-of-school (OOS) girls.

Per Diem includes travel allowance.

^**

Personnel time was US$ 0 in financial costs because no contracted personnel for the HPV vaccination program were found in the data analysis. Therefore, all personnel time was an economic cost.